Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Androgen-producing ovarian tumors can cause male-pattern hair loss in women.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Monitoring for adverse effects in clinical treatments is crucial.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Hormones affect skin aging, and treatments targeting hormonal balance may improve skin health.